David H Smith

Author PubWeight™ 108.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004 7.79
2 Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012 6.26
3 Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011 5.25
4 Prescription drug use in pregnancy. Am J Obstet Gynecol 2004 4.92
5 Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA 2013 3.30
6 ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 2011 2.77
7 Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2007 2.61
8 Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care 2005 2.33
9 Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc 2006 2.33
10 Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003 2.19
11 How to design computerized alerts to safe prescribing practices. Jt Comm J Qual Saf 2004 2.11
12 The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes 2008 2.03
13 Estimating utility data from clinical indicators for patients with stable angina. Eur J Health Econ 2005 1.78
14 Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 2006 1.73
15 Reducing warfarin medication interactions: an interrupted time series evaluation. Arch Intern Med 2006 1.67
16 AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol 2008 1.57
17 Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis 2008 1.54
18 Trends in elective labor induction for six United States health plans, 2001-2007. J Womens Health (Larchmt) 2014 1.54
19 Automated telephone calls improved completion of fecal occult blood testing. Med Care 2010 1.50
20 Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product. Am Heart J 2004 1.44
21 Computerized prescribing alerts and group academic detailing to reduce the use of potentially inappropriate medications in older people. J Am Geriatr Soc 2006 1.40
22 Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am 2003 1.40
23 Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 2009 1.38
24 Improved therapeutic monitoring with several interventions: a randomized trial. Arch Intern Med 2006 1.37
25 The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int 2005 1.35
26 Weight change in diabetes and glycemic and blood pressure control. Diabetes Care 2008 1.34
27 Predicting renal replacement therapy and mortality in CKD. Am J Kidney Dis 2007 1.34
28 Systolic blood pressure and mortality among older community-dwelling adults with CKD. Am J Kidney Dis 2010 1.24
29 Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf 2008 1.21
30 Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf 2012 1.20
31 Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc 2013 1.12
32 Medication Exposure in Pregnancy Risk Evaluation Program. Matern Child Health J 2012 1.08
33 Effect of a patient panel-support tool on care delivery. Am J Manag Care 2010 1.08
34 Change to FIT increased CRC screening rates: evaluation of a US screening outreach program. Am J Manag Care 2012 1.05
35 Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations. Pharmacoepidemiol Drug Saf 2009 1.03
36 Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health 2013 1.03
37 Use of health information technology to improve medication adherence. Am J Manag Care 2011 1.03
38 Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. Nephrology (Carlton) 2006 1.01
39 Impact of comorbidities on mortality in managed care patients with CKD. Am J Kidney Dis 2006 1.01
40 Correlates of higher-dose opioid medication use for low back pain in primary care. J Pain 2012 0.99
41 Potential drug-drug interactions in the outpatient setting. Med Care 2006 0.96
42 Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med 2013 0.93
43 Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study. J Am Geriatr Soc 2013 0.93
44 Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Nephrology (Carlton) 2009 0.93
45 Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med 2010 0.93
46 Nurse-coordinated care in CKD: time for translation into practice? Clin J Am Soc Nephrol 2011 0.91
47 Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting. Infect Control Hosp Epidemiol 2012 0.91
48 Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans. Med Care 2007 0.91
49 Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf 2013 0.90
50 Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients. BMC Fam Pract 2013 0.90
51 Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes 2012 0.89
52 Weight change and glycemic control after diagnosis of type 2 diabetes. J Gen Intern Med 2008 0.89
53 Managing the burden of chronic kidney disease. Dis Manag 2006 0.88
54 Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007. Obstet Gynecol 2013 0.87
55 Predicting the risk of end-stage renal disease in the population-based setting: a retrospective case-control study. BMC Nephrol 2011 0.86
56 A primary care-based interdisciplinary team approach to the treatment of chronic pain utilizing a pragmatic clinical trials framework. Transl Behav Med 2012 0.86
57 Reducing the prescribing of heavily marketed medications: a randomized controlled trial. J Gen Intern Med 2009 0.86
58 Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril. Pharmacoepidemiol Drug Saf 2010 0.85
59 Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes. Pharmacoepidemiol Drug Saf 2013 0.85
60 Primary care colorectal cancer screening recommendation patterns: associated factors and screening outcomes. Med Decis Making 2011 0.85
61 Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population. Circ Heart Fail 2013 0.85
62 An outreach program improved osteoporosis management after a fracture. J Am Geriatr Soc 2007 0.84
63 Proteinuria among patients with chronic kidney disease: a performance measure for improving patient outcomes. Jt Comm J Qual Patient Saf 2012 0.84
64 Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates. Pharmacoepidemiol Drug Saf 2010 0.84
65 Health care worker perspectives inform optimization of patient panel-support tools: a qualitative study. Popul Health Manag 2012 0.83
66 Predicting poor outcomes in heart failure. Perm J 2011 0.83
67 Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]). Am J Cardiol 2013 0.81
68 More comprehensive discussion of CRC screening associated with higher screening. Am J Manag Care 2013 0.80
69 Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure. Circ Heart Fail 2013 0.79
70 Comparison of antibiograms developed for inpatients and primary care outpatients. Diagn Microbiol Infect Dis 2013 0.79
71 Clostridium difficile infection, Colorado and the northwestern United States, 2007. Emerg Infect Dis 2012 0.79
72 Improving adherence to cardiovascular disease medications with information technology. Am J Manag Care 2014 0.78
73 The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007. Matern Child Health J 2014 0.78
74 Predicting mortality in older adults with kidney disease: a pragmatic prediction model. J Am Geriatr Soc 2015 0.77
75 Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT. Eur J Cancer Prev 2014 0.75
76 Evaluation of drug utilization review programs. JAMA 2004 0.75
77 Theological reflection and the new biology. Indiana Law J 1973 0.75
78 On letting some babies die. Stud Hastings Cent 1974 0.75
79 Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women. Am J Epidemiol 2017 0.75
80 Understanding suffering. Hastings Cent Rep 1992 0.75
81 On Paul Ramsey: a covenant-centered ethic for medicine. Second Opin 1987 0.75
82 Comparison of renal replacement therapy and mortality using 1 versus 2 estimated glomerular filtration rates. Popul Health Manag 2009 0.75
83 Taking religion seriously. Hastings Cent Rep 2007 0.75
84 Communication as a reflection of, and a source for, values in health. J Appl Commun Res 1988 0.75
85 Quality, not mercy: some reflections on recent work in medical ethics. Med Humanit Rev 1991 0.75
86 Who counts? J Relig Ethics 1984 0.75
87 Telling stories as a way of doing ethics. Conn Med 1987 0.75
88 What do medical records tell us about potentially harmful co-prescribing? Jt Comm J Qual Patient Saf 2007 0.75
89 Should measuring haemoglobin among chronic kidney disease patients be a performance measure? J Evid Based Med 2012 0.75
90 A response to Beauchamp. Indiana Law J 1994 0.75
91 The state of cost-effectiveness analysis in American managed care. Expert Rev Pharmacoecon Outcomes Res 2006 0.75
92 Predicting chronic kidney disease outcomes: are two estimated glomerular filtration rates better than one? Popul Health Manag 2012 0.75
93 Wombs for rent, selves for sale? J Contemp Health Law Policy 1988 0.75
94 Religion and the use of animals in research: some first thoughts. Ethics Behav 1997 0.75
95 Research on the brain-dead. IRB 1980 0.75